Publications

Publications in the past year (AY 2004-2007), directors and fellows, color-coded

•  Kapp N , Borgatta L , Stubblefield PG , Vragovic O, Moreno N. A randomized, placebo-controlled, double-blind study of mifepristone in midtrimester termination of pregnancy

•  Wataganara T, Chen AY , LeShane ES, Sullivan L, Borgatta L, Bianchi DW, Johnson KL. Cell-free fetal DNA levels in maternal plasma after elective first trimester termination of pregnancy. Fertil Steril 2004

•  Stubblefield PG , Carr-Ellis S , Borgatta L . Methods for induced abortion. Obstet Gynecol 2004;104:174-85.

•  Wataganara T, LeShane E, Chen AY , Borgatta L , Johnson K, Bianchi D. Plasma Gamma Globin gene expression suggests that fetal hematopoietic cells contribute to the pool of cell-free fetal nucleic acids in pregnancy, Clin Chem 2004:50-689-93.

•  Borgatta L , Mullally B*, Vragovic O, Gittinger E*, Chen AY . Misoprostol as the primary agent for medical abortion in a low-income urban setting, in press, Contraception 2004;70:121-6.

•  Wataganara T, Peter I, Messerlian GM, Borgatta L , Bianchi DW. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol 2004;104:545-50.

•  Wataganara T, Chen AY , LeShane ES, Sullivan L, Borgatta L , Bianchi DW, Johnson KL. Elevated cell-free fetal DNA levels in maternal plasma following elective termination of pregnancy after 9 weeks of gestation. . Clin Chem 2004;51:217-9.

•  Wataganara T . Chen AY . LeShane ES. Sullivan LM. Borgatta L . Bianchi DW. Johnson KL. Changes of cell-free fetal DNA in maternal plasma after elective termination of pregnancy. Clinical Chemistry. 2005;51(1):217-9.

•  Kapp N , Borgatta L , Carr-Ellis S , Vragovic O , Stubblefield PG . Simultaneous mifepristone and vaginal misoprostol for medical abortion: how low can you go? Obstet Gynecol 2005;105:57S . and Contraception 2006;73:525-527.

•  Borgatta L , Chen AY , Vragovic O, Stubblefield PG , Magloire CA*. Randomized clinical trial of laminaria and misoprostol vs. misoprostol alone for second trimester induction abortion. Contraception 2005;72: 358-361.

•  Chen AY , Mottl-Santiago J, Vragovic O, Wasserman S*, Borgatta L . Length of bleeding after medical termination of pregnancy using two dosing schedules of mifepristone and misoprostol. Contraception 2006;73:415-419 .

•  Wang,X, Laird N, Zuckerman B, Stubblefield PG , Xu, X: Polymorphism in maternal LRP8 is associated with fetal growth. Amer. J. Human Genetics: 2006;78:770-7

•  Odell, CD, Kotelchuck, M, Chetty, VK, Fowler, J, Stubblefield PG , Orejuela, M, Jack, BW: Maternal hypertension as a risk factor for low birth weight infants: comparison of Haitian and African-American  women.  Maternal and Child Health Journal 2006:10: 39-46

•  Jeong YL, Borgatta L , Kapp N , Peter I , Bianchi DW , Johnson KL Short-term clearance of cell-free nucleic acids after first-trimester termination of pregnancy Fertil Steril. 2007 May

•  Moreno NL , Borgatta L , Yanow S, Kapp N, Stubblefield PG . Alternatives to mifepristone for early medical abortion, Int J Gynecol Obstet 2007;96:212-218

•  Gupta M, Mestan KK, Martin CR, Pearson C, Ortiz K, Fu L, Stubblefield PG , Cerda S, Kasznica JM, Wang X. Impact of clinical and histology correlates of maternal and fetal inflammatory response on gestational age in preterm births. J. Maternal Fetal and Neonatal Medicine. 2007; 20:39 -46.

 

In press

•  Green J, Borgatta L , Sia, M, Kapp N Saia K, Carr-Ellis S , , Vragovic O. Intervention rates for placental removal following induction abortion with misoprostol, in press, Contraception

•  Kapp N , Todd CS, Yadgarova KT, Alibayeva G, Nazarova D, Loza O, Guldjahan SB. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2 analogue for second trimester induction termination in Uzbekistan . In press, Contraception

•  Prairie BA, Lauria M, Kapp N , MacKenzie T, Baker E, George KA. Mifepristone versus Laminaria: A Randomized Controlled Trial of Cervical Ripening in Midtrimester Termination.  Contraception, in press.

 

Submitted:

•  Creinin MD, Meyn LA. Borgatta L et. al. A randomized, multi-center trial to evaluate continuation rates, side effects and acceptability of the contraceptive ring versus the contraceptive patch.

 

Book chapters:

•  Stubblefield PG . Pregnancy termination. In: Noller, K, Ed. Precis Gynecology, 3 rd edition Washington , DC., The American College of Obstetricians and Gynecologists. 2005.

•  Stubblefield PG, Borgatta, L : Complications after induced abortion in Pearlman ED, Tintinalli JE, Dyne PL, Eds. Emergency Care of the Woman: Diagnosis and Management , New York, McGraw Hill, 2004, p. 65-86.

•  Stubblefield PG , Carr-Ellis S , Kapp N . Family Planning , in Berek J, ed, Novak's Gynecology, 14 th edition , Lippincott, Williams, and Wilkins, Philadelphia, 2006.

•  Kapp N , Borgatta L . Study design for hormonal contraceptive research. In Burkman R, Clinical Obstetrics and Gynecology. In press

•  Borgatta L , Betstadt S . Abnormal uterine bleeding, In Stovall T and Ling F. Gynecology for the Primary Care Physician.2 nd ed . In press